Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Polyacrylamide hydrogel + silver ions** is a **composite wound dressing** material consisting of a synthetic polymer hydrogel matrix—polyacrylamide (PAA)—incorporated or loaded with silver ions, most commonly in the form of silver nanoparticles (AgNPs). The hydrogel acts as a moist wound interface and carrier for the controlled, localized delivery of silver ions, which provide broad-spectrum antibacterial activity. The mechanism of action combines the hydrogel's ability to maintain a suitable wound-healing environment with the antimicrobial effects of silver, which disrupts bacterial cell membranes, interacts with bacterial DNA, and generates reactive oxygen species. This formulation has shown efficacy against both standard and antibiotic-resistant bacteria, reduced wound size, and promoted healing in preclinical studies and limited clinical testing for chronic ulcers and wound infections[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polyacrylamide hydrogel + silver ions.